Investors / Italy / Angelini Ventures
Angelini Ventures
Corporate VC · Rome, Italy · Europe
Angelini Ventures is the corporate venture capital firm of Angelini Industries, investing in BioTech and HealthTech companies. It backs companies working to make healthcare smarter and to reinvent the patient journey, with a €300 million commitment.
Invests inHealthcare & Biotech
In its own wordshealthtechbiotechdigital healthmedtechlife sciencescns
Your fit with Angelini Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAngelini Ventures lists 29 checked portfolio companies on its own site and is named in 17 funding rounds, 3 of them as lead. Its most frequent entry is Series A, 33% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 31% of its companies are based in United States. It invests most often alongside Kurma Partners, CDP Venture Capital and Lumira Ventures.
Counts come from funding rounds that name Angelini Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 20% |
| Series A | 33% |
| Series B | 27% |
| Growth | 20% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 6 | 2 |
| '26 | 11 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 66th | 29 companies |
| Recent activity | 95th | 11 rounds in 12 months |
| Early stage | 58th | 20% of entries at pre-seed or seed |
| Evidence | 99th | 45% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 95th | 10 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Kurma Partners | 7 |
| CDP Venture Capital | 5 |
| Lumira Ventures | 4 |
| Indaco Venture Partners SGR | 3 |
| Kerna Ventures | 3 |
| Sanofi Ventures | 3 |
| 360 Capital | 2 |
| HighLight Capital | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers29100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Angelini Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Angelini Ventures| Date | Company | Stage |
|---|---|---|
| 19 Oct 2026 | Series C+ | |
| 8 Oct 2026 | Series C+ | |
| 6 Oct 2026 | Series A Led | |
| 29 Sept 2026 | Seed | |
| 16 Sept 2026 | Series C+ | |
| 10 Aug 2026 | Series C+ | |
| 6 Jul 2026 | Series B | |
| 18 Jun 2026 | Series B |
Round details for Angelini Ventures
Amounts, full round histories and every co-investor in Angelini Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
29 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Adcytherix is building an antibody-drug conjugate powerhouse to advance patient-need-driven therapies | Healthcare & Biotech | Oct 2025Series A | Page + round | |
| AptaDir develops RNA-based therapeutics to reprogram DNA methylation in disease conditions | Healthcare & Biotech | Sept 2026Seed | Page + round | |
| Argobio Studio builds the next generation of European biotech champions by turning scientific discoveries into investable companies | Healthcare & Biotech | Portfolio page | ||
| Cadence Neuroscience is developing a platform for personalized neuromodulation to help people achieve seizure freedom | Healthcare & Biotech | Portfolio page | ||
| CoMind develops non-invasive neurotechnology to measure and treat the brain | Healthcare & Biotech | Oct 2025Series A · 2 rounds | Page + round | |
| Congruence Therapeutics is a clinical-stage biotechnology company that discovers and develops small molecule correctors and allosteric modulators to ameliorate disease conditions at the molecular level. | Healthcare & Biotech | Portfolio page | ||
| COUR Pharma develops targeted therapies for autoimmune diseases | Healthcare & Biotech | Jun 2026Series B | Page + round | |
| Damona Pharmaceuticals is developing therapies to reverse cognitive deficits and restore contact between brain cells | Healthcare & Biotech | Portfolio page | ||
| The company provides a technological tool to simplify and speed up the blood donation process | Healthcare & Biotech | Jun 2026Seed | Funding round | |
| Elkedonia is developing a neuroplastogen for antidepressant therapy | Healthcare & Biotech | Portfolio page | ||
| Ema Health develops digital tools for blood and plasma collection centers and donor associations | Healthcare & Biotech | Jun 2026Seed | Funding round | |
| Epicrispr Biotechnologies develops therapies to dynamically control gene expression and treat complex disease | Healthcare & Biotech | Aug 2026Series C+ | Page + round | |
| Extend aims to identify novel targets and innovative therapeutics approaches originating from academic research and develop these through an integrated drug discovery process to create new start-ups that can bring science to patients. | Healthcare & Biotech | Portfolio page | ||
| Freya Biosciences is a clinical-stage immunology company developing therapies to address inflammation and immune dysregulation in conditions affecting women. | Healthcare & Biotech | Portfolio page | ||
| Handspring Health provides therapy for children and young adults with various mental health challenges | Healthcare & Biotech | Jul 2026Series B | Page + round | |
| Hypervision Surgical develops and uses AI-powered hyperspectral imaging to help surgeons make more precise and safer decisions during operations | Healthcare & Biotech | Apr 2026Series A | Page + round | |
| Laigo Bio develops targeted therapies using protein degradation technology | Healthcare & Biotech | Portfolio page | ||
| The company develops and provides robotic microsurgery systems and instruments for surgeons to perform complex procedures with greater precision and control. | Healthcare & Biotech | Sept 2026Series C+ · 2 rounds | Page + round | |
| Neumirna Therapeutics develops miRNA-based therapies for neurological diseases | Healthcare & Biotech | Portfolio page | ||
| Nobi provides technology for senior living, including fall prevention and detection, nurse call systems, and sleep improvement solutions | Healthcare & Biotech | Portfolio page |
About this data
site last read 11 Nov 2026- Site
- angeliniventures.com
- Last read
- 11 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 6 May 2025
- Companies checked
- 29
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Angelini Ventures' profile as data
Pull Angelini Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/angeliniventures.com
# also
GET /v1/firms/angeliniventures.com/portfolio
GET /v1/firms/angeliniventures.com/coinvestors
GET /v1/firms/angeliniventures.com/news